FundedIQ
Biotechnology

TissueForm: Funding, Investors & Team (Aug 2026)

TissueForm is passionate about improving life for people with volumetric tissue loss by harnessing the natural, restorative power of the extracellular matrix. TissueForm advances novel biomaterials to address clinical problems in plastic surgery and regenerative medicine. We create biomaterials of cross-linkable tissue and protein components which mimic natural tissue upon injection.

www.tissueforminc.com Boulder, United States 1-10 employees
Biotechnology Cosmetic Surgery Health Care Medical Medical Device B2C Biomaterials Dermal filler
Total raised
$250k
Rounds
1
Latest
Undisclosed round
May 2023

TissueForm has raised $250k across 1 funding round on record, the most recent an undisclosed round of $250k announced in May 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

TissueForm Company Profile and Key Stats

Total funding raised
$250k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$250k in May 2023
Employees
1-10
reported band
Headquarters
Boulder, United States

Latest funding round on record: May 2023.

TissueForm Funding Rounds

Date
Round
Amount
Undisclosed round
$250k

TissueForm Founders and Leadership Team

Name
Role
Contact
Jeanne Barthold
Founder
Locked

Contact details for the TissueForm team: 1 of 1 has an email address on file.

Start 14-day free trial →

TissueForm Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

TissueForm's latest round of $250k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like TissueForm in Biotechnology and Boulder

Companies Similar to TissueForm

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

TissueForm Funding FAQs

What does TissueForm do?

TissueForm is passionate about improving life for people with volumetric tissue loss by harnessing the natural, restorative power of the extracellular matrix. TissueForm advances novel biomaterials to address clinical problems in plastic surgery and regenerative medicine. We create biomaterials of cross-linkable tissue and protein components which mimic natural tissue upon injection.

How much funding has TissueForm raised?

TissueForm has raised $250k across 1 round on record. The most recent is an undisclosed round of $250k announced in May 2023.

When did TissueForm last raise funding?

TissueForm's most recent funding round on record is an undisclosed round of $250k, announced in May 2023.

Who founded TissueForm?

FundedIQ lists Jeanne Barthold (Founder) at TissueForm.

Where is TissueForm headquartered?

TissueForm is based in Boulder, Colorado, United States.

How many employees does TissueForm have?

TissueForm is in the 1-10 employee band.

How does TissueForm's funding compare to other Biotechnology startups?

TissueForm's latest round of $250k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's TissueForm Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TissueForm is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.